Company intelligence / Profile preview

Changchun Haobang Pharmaceutical

Jilin, China

Ownership: Private
Development stage: Other

Overview

Changchun Haobang Pharmaceutical (also known as Changchun Haobang Health Technology Co., Ltd.) is an active, independent pharmaceutical and health technology company, founded in 2013 and headquartered in Jilin, China. As of 2023, the company holds 38 patents, indicating its engagement in R&D and intellectual property. No specific information on clinical pipeline, key people, partnerships, or revenue is publicly available.

Industry: Biotech

Beyond the preview

Go deeper on Changchun Haobang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changchun Haobang Pharmaceutical.

Explore the full profile